The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


CRX  CYPROTEX PLC  ORD 0.1P

CYPROTEX  Currency GBX 
Company




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
14:06 21-May-2013 CRX Holding(s) in Company RNS +4.29% Up
14:05 21-May-2013 CRX Holding(s) in Company RNS +4.29% Up
07:00 01-May-2013 CRX Contract with U.S. EPA RNS +4.61% Up
07:00 21-Mar-2013 CRX Final Results RNS -2.60% Down
07:00 15-Mar-2013 CRX Notice of Results RNS -1.29% Down
12:05 26-Feb-2013 CRX Holding(s) in Company RNS 0.00% 
12:05 26-Feb-2013 CRX Holding(s) in Company RNS 0.00% 
07:00 14-Feb-2013 CRX Launch of new cardiotoxicity service-eCiphrCardio RNS 0.00% 
10:45 11-Jan-2013 CRX Replacement - Issue of Equity RNS 0.00% 
07:00 11-Jan-2013 CRX Issue of Equity RNS 0.00% 
07:00 13-Dec-2012 CRX Trading Statement RNS -16.96% Down
07:00 30-Oct-2012 CRX Re Agreement with Pfizer RNS +9.20% Up
07:00 29-Oct-2012 CRX Change of NOMAD Name RNS +11.76% Up
07:00 16-Oct-2012 CRX Licensing Agreement with Sigma Life Science RNS -0.61% Down
07:00 20-Sep-2012 CRX CellCiphr Premier Launch RNS 0.00% 
07:00 06-Sep-2012 CRX Half Yearly Report RNS -16.51% Down
07:00 06-Sep-2012 CRX Joint Service Offering RNS -16.51% Down
07:00 04-Sep-2012 CRX Notice of Results RNS -21.76% Down
07:00 04-Sep-2012 CRX Board Change RNS -21.76% Down
07:00 02-Aug-2012 CRX Updated Regulatory Guidance Booklet RNS +4.39% Up

 Page 1 of 2

| 1 | 2 | Next


CYPROTEX - News Analysis

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds